Metabolic effects of poly (ADP-ribose) inhibitors.
D062365:Aminobenzoates / Q000494:pharmacology; D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D019817:Benzoic Acid; D002245:Carbon Dioxide / Q000378:metabolism; D002460:Cell Line; D004247:DNA / Q000096:biosynthesis; D005947:Glucose / Q000378:metabolism; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D009702:Nucleoside Diphosphate Sugars / Q000037:antagonists & inhibitors*; D011064:Poly Adenosine Diphosphate Ribose / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D062368:meta-Aminobenzoates
D062365:Aminobenzoates; D001549:Benzamides; D001565:Benzoates; D009702:Nucleoside Diphosphate Sugars; D062368:meta-Aminobenzoates; D002245:Carbon Dioxide; D011064:Poly Adenosine Diphosphate Ribose; C037689:benzamide; C025160:3-aminobenzamide; D019817:Benzoic Acid; D004247:DNA; D007770:L-Lactate Dehydrogenase; C044855:3-aminobenzoic acid; D005947:Glucose